A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Clinical trial NCT07705334 · RECRUITING

Trial details

NCT number: NCT07705334
Sponsor: SHY Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors Triple Negative Breast Cancer (TNBC)HR+ Breast Cancer Colon Cancer Gastric Cancer Hepatecellular Carcinoma NSCLC (Advanced Non-small Cell Lung Cancer)Mesothelioma Pancreatic Carcinoma Metastatic Hormone Refractory Prostate Cancer Soft Tissue Sarcomas

Start date: 2026-06-24
Primary completion: 2027-05-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.